All News
Increased Adverse Pregnancy Outcomes in Ankylosing Spondylitis
Although ankylosing spondylitis affects a predominantly male population, the ratio of men to women has declined from 9-10:1 in earlier studies to more recent estimates of 2-3:1 (F:M).
Read ArticleChanging Patterns of Drug Use in Pregnant Rheumatic Patients: Steroids Down, Biologics Up
Desai and coworkers analyzed public and private insurance claims data (2001-2012) to assess patterns of drug use in pregnant woment with RA, SLE, PsA and AS. Specifically, they looked at immunosuppressive drug use in the 3 months preceding and during pregnancy.
Read ArticleFertility in RA Linked to Disease Activity, NSAIDs and Prednisone
Brouwer and colleagues from the University Medical Center Rotterdam in The Netherlands have studied the issue of infertility in a cohort of RA patients followed prospectively.
Read ArticleDSB: ACR 2015 Safety Reports
The following is a compilation of abstracts presented at the 2015 Annual ACR meeting in San Francisco. These were chosen on the basis of impact, quality and safety message.
Read ArticleConcern Still Lingers for Silicone Breast Implants
What do you tell your patients who are considering augmentation mammoplasty? Or who question the safety of prior implants?
Read ArticleInfertility in Rheumatoid Arthritis Linked to Disease Activity
Women with rheumatoid arthritis are said to have a normal number of pregnancies. However, most of these are conceived prior to the onset of RA. Once diagnosed, the RA patient who wishes to become pregnant may be faced with difficult medication choices if she is planning to become pregnant.
Read ArticleAngiogenic Biomarkers Predict Adverse Outcomes Pregnancies in Lupus
The PROMISSE (Predictors of Pregnancy Outcome: Biomarkers in Antiphospholipid Antibody Syndrome and Systemic Lupus Erythematosus) study has revealed several important lessons in lupus care.
Read ArticlePLLR - The Pregnancy & Lactation Labeling Rule Explained
A recent article from Healio.com reviewed the FDA’s Pregnancy and Lactation Labeling Rule (PLLR) that became effective June 30th.
Read ArticleProlonged Breastfeeding Associated with Postmenopausal Osteoporosis
The effects of prior breastfeeding on bone density of postmenopausal women have been controversial. Several studies suggest that breastfeeding and childbirth lead to maternal calcium loss and a decline in bone mineral density (BMD).
Read ArticleIncreasing Age May Increase Miscarriage Risk in RA
At EULAR 2015, Brouwer and colleagues reported on their cohort of 162 evaluable pregnancies in 239 Dutch women enrolled during 2002-2010 in the nationwide Pregnancy-Induced Amelioration of Rheumatoid Arthritis (PARA) study – a large prospective cohort of pregnant RA patients.
Read ArticleHalf of US Women are Overweight during Pregnancy
Obesity is associated with adverse outcomes in pregnancy, especially with higher rates of infertility and miscarriage.
Read ArticleHigh Lupus Flare and Complication Rates in Lupus Pregnancy
An incident cohort study from Denmark showed that 84 SLE pregnancies resulted in 62 live births. Lupus disease activity strongly influenced maternal complications seen in half and fetal complications were observed in one-third of cases.
Read ArticleThe EULAR 2015 Report - Wednesday
EULAR 2015 started the afternoon of Wednesday June 10th.
Read ArticleSafety of Azathioprine in SLE Pregnancy Studied
Read Article
FDA Enforces New Drug Safety Labeling for Pregnant Women
The traditional FDA pregnancy risk categories (A, B, C, D, X) have been scrapped in favor of a new labeling mandate called the pregnancy and lactation labeling rule (PLLR). This change has been under consideration at the FDA for nearly 2 years and was brought about by the belief that the old
Read Article